Macerich invests in premium mall assets... Show more
Macerich is a fully integrated, self-managed, self-administered real estate investment trust (REIT) headquartered in Santa Monica, California. The company owns, operates, leases, and redevelops high-quality regional shopping centers, with a portfolio of roughly 39 to 40 million square feet concentrated in densely populated, affluent U.S. markets including California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to Washington, D.C. corridor. Approximately 90% of its net operating income comes from Class A mall properties.
Investors follow the stock closely because of its exposure to Class A regional mall fundamentals, occupancy and leasing momentum, funds from operations (FFO), and balance-sheet leverage. Management's "Path Forward" plan — built around re-leasing about 1,000 units, a signed-not-open (SNO) revenue pipeline, roughly $2 billion in planned dispositions, and debt reduction — is central to the company's effort to improve FFO per share and lower leverage.
Over the last 30 days, Macerich shares rose approximately 13.3%, moving from a closing price near $22.87 to about $25.91. The advance was back-loaded, with much of the move occurring after the stock bottomed near the low $22 area in early October and then staged a steady recovery through the final weeks of the period.
The broader quarterly picture is notably different. Measured from early August, when shares traded near $25.6, the stock is essentially little changed at roughly $25.9 — a gain of only about 1%. That modest net result, however, masks meaningful volatility: the stock slid from its 52-week-high territory into the low $22 range by late September and early October before rebounding. The quarter therefore reflects a V-shaped round trip rather than a steady advance.
The recent upswing was supported by a wave of constructive sell-side activity. In late September, J.P. Morgan upgraded Macerich to Buy with a $26 price target. In early October, Truist assumed coverage with a Buy rating and a $26 target, citing limited retail supply, high occupancy, and low tenant credit losses as supportive of retail fundamentals. Exane BNP Paribas initiated coverage with a Buy rating and a $28 target, while Piper Sandler reaffirmed a Buy rating with a $26 target.
The stock also benefited from positioning ahead of the company's third-quarter 2026 earnings release, scheduled for November 4 after the market close. After the early-October pullback left shares oversold relative to the surrounding analyst price targets, buyers stepped in, and the name rebounded as sentiment improved across the mall REIT group. The move reflects a combination of analyst upgrades, improving risk appetite toward retail real estate, and renewed optimism about Macerich's leasing and deleveraging trajectory.
The last quarter was shaped by two competing forces. In early August, Macerich reported second-quarter 2026 funds from operations of $0.35 per share, exceeding the consensus estimate of $0.33. That beat was not enough to prevent a broader pullback, however, as the stock fell sharply in early August and trended lower through September amid interest-rate and REIT-sector volatility. By early October, shares had retreated to the low $22 range.
The subsequent recovery was driven by the analyst upgrades and initiations described above, plus a broader rotation back into high-quality retail landlords. Investors also continue to weigh the company's "Path Forward" milestones — including a growing signed-not-open pipeline, anchor backfill progress, and debt reduction — as evidence that Class A mall fundamentals remain resilient even in a higher-rate environment. The net result over the full quarter has been a return to roughly its starting level.
Tickeron offers hundreds of AI trading bots that monitor thousands of tickers across the market. Only the top-performing and most relevant bots appear in the curated Trending AI Robots section, which is designed to help traders identify strategies that are currently standing out. These bots vary by strategy, timeframe, and performance metrics, so the section serves as a starting point for exploring automated approaches rather than a one-size-fits-all recommendation. Traders interested in systematic, data-driven ideas can review the list to see which strategies are gaining momentum across different asset classes and market conditions.
The most immediate catalyst is Macerich's third-quarter 2026 earnings report and conference call, which provide updated detail on FFO, occupancy, and leasing activity. Beyond the quarter, investors are likely to focus on the "Path Forward" plan's execution: the ramp of the signed-not-open pipeline toward its target, progress toward the 88%–89% occupancy goal, the pace of the roughly $2 billion disposition program, and further debt reduction.
Macroeconomic factors also matter. As a REIT, Macerich is sensitive to interest-rate movements, which influence both financing costs and valuation multiples. Consumer spending trends, tenant credit quality, and any additional retailer bankruptcies or store closures represent ongoing risks. On the upside, continued strength in Class A mall demand, limited new supply, and anchor backfills could support further operational improvement. Analyst sentiment currently skews constructive, with a consensus Buy rating and average price targets clustered in the mid-to-high $20s, but actual results will depend on execution and the broader rate environment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MAC declined for three days, in 191 of 276 cases, the price declined further within the following month. The odds of a continued downward trend are 69%.
The 10-day RSI Indicator for MAC moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 22 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 67%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 38 of 61 cases where MAC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 62%.
MAC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on MAC as a result. In 63 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.
MAC moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MAC crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Following a +2.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where MAC advanced for three days, in 216 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
The Aroon Indicator entered an Uptrend today. In 166 of 265 cases where MAC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. MAC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 44 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 59, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.491) is normal, around the industry mean (2.797). MAC has a moderately low P/E Ratio (-37.636) as compared to the industry average of (36.193). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (12.808). Dividend Yield (0.027) settles around the average of (339.763) among similar stocks. P/S Ratio (5.807) is also within normal values, averaging (6.739).
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a real estate investment trust
Industry RealEstateInvestmentTrusts